BETA

3 Amendments of Gunnar BECK related to 2021/2013(INI)

Amendment 63 #
Draft opinion
Paragraph 4 a (new)
4a. Calls on the Commission to revise the legal framework for the protection of the pharmaceuticals market or pharmaceutical data, so as to improve access to generic and biosimilar medicines, offering affordable treatments to a large number of patients, with better prices being charged by competitors as a result, thereby reducing health costs;
2021/06/03
Committee: JURI
Amendment 76 #
Draft opinion
Paragraph 5 a (new)
5a. Notes that EU joint procurement agreements to address the COVID-19 crisis have not proven their effectiveness in the eyes of the Member States; stresses that such agreements fall within the competence of the Member States - and not the Commission - and help to mitigate the impact of cross-border health threats and guarantee increased security of supply;
2021/06/03
Committee: JURI
Amendment 77 #
Draft opinion
Paragraph 5 b (new)
5b. Stresses the need to relocate the production of the most essential medicines into the EU; calls, therefore, on the Commission to prioritise the pharmaceutical production of vaccines in the EU, enabling Member States to conclude public contracts with the various European pharmaceutical laboratories producing vaccines in order to avoid a shortage of doses and ensure the safety of European citizens in the face of such a crisis;
2021/06/03
Committee: JURI